Pharmacovigilance-as-a-Service โข AI-Powered โข Coming Soon
Our mission is to modernize pharmacovigilance by enabling life-science organizations to detect, assess, and act on drug safety information more efficiently. Helping protect patients while reducing operational burden on safety teams.
As drug discovery and development increasingly leverage AI and advanced analytics, pharmacovigilance teams face growing volumes and complexity of safety data, creating an urgent need for modern, scalable safety infrastructure.
Daivox is being built as an AI-powered, cloud-native, API-first platform, designed to integrate seamlessly with existing safety ecosystems and scale with global pharmacovigilance needs.
Why Daivox
Platform Principles
AI-Powered by Design
Machine learning models assist with case triage, prioritization, and signal exploration โ supporting human reviewers rather than replacing clinical judgment.
Cloud-Native Architecture
Built on modern cloud infrastructure to enable secure data handling, elastic scalability, and high availability across global safety operations.
API-First & Interoperable
APIs are core to the platform, enabling seamless integration with safety databases, EDC systems, literature tools, and downstream analytics.
Planned PVaaS Capabilities
Daivox is being developed to support the full pharmacovigilance lifecycle while remaining flexible to each organization's operating model.
Case Intake & Processing Support
Structured intake of Individual Case Safety Reports (ICSRs) from multiple sources with workflow and validation support.
Intelligent Case Triage
AI-assisted prioritization to help identify serious, expedited, and high-risk cases earlier in the review process.
Literature & Safety Signal Monitoring
Automated monitoring of scientific literature and external data sources to assist with signal detection and evaluation.
Safety Analytics & Insights
Dashboards designed to surface trends, emerging risks, and operational KPIs for PV teams.
Audit Readiness & Traceability
Support for documentation, traceability, and inspection readiness aligned with global pharmacovigilance expectations.
Join the Early Access List
We're collaborating with early partners to shape Daivox around real-world pharmacovigilance challenges and regulatory realities.